News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

C.R. Bard Said to Settle Vaginal-Mesh Case Set for Trial


9/16/2013 7:36:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

C.R. Bard Inc. agreed to settle a woman’s claims that one of its vaginal-mesh implants caused internal problems before a trial set for this month in New Jersey, two people familiar with the accord said. Bard officials agreed to pay an undisclosed sum to resolve Melanie Virgil’s claims that Bard’s Avaulta Plus insert caused urinary problems, said the people, who asked not to be named because they weren’t authorized to speak publicly about the settlement. Virgil’s case had been set for a Sept. 23 trial in state court in Atlantic City, according to court dockets.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
C.R. Bard
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES